SLDB Other | Solid Biosciences Inc.

Solid Biosciences Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-03-19: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market.
2025-03-06: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market.
2024-05-15: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market.
2024-03-13: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market.

Filed	Form	Item	As filed
2026-03-19	10-K	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2025-03-06	10-K	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2024-05-15	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2024-03-13	10-K	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2023-11-08	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2023-11-08	10-Q	Emerging growth company	Yes
2023-08-14	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2023-08-14	10-Q	Emerging growth company	Yes
2023-05-11	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2023-05-11	10-Q	Emerging growth company	Yes
2023-03-23	10-K	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2023-03-23	10-K	Emerging growth company	Yes
2022-11-10	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2022-11-10	10-Q	Emerging growth company	Yes
2022-08-11	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2022-08-11	10-Q	Emerging growth company	Yes
2022-04-27	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2022-04-27	10-Q	Emerging growth company	Yes
2022-03-14	10-K	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2022-03-14	10-K	Emerging growth company	Yes
2021-11-03	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2021-11-03	10-Q	Emerging growth company	Yes
2021-08-16	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2021-08-16	10-Q	Emerging growth company	Yes
2021-05-14	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2021-05-14	10-Q	Emerging growth company	Yes
2021-03-15	10-K	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2021-03-15	10-K	Emerging growth company	Yes
2020-11-05	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2020-11-05	10-Q	Emerging growth company	Yes
2020-08-06	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · The Nasdaq Global Select Market
2020-08-06	10-Q	Emerging growth company	Yes
2020-05-07	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · NASDAQ
2020-05-07	10-Q	Emerging growth company	Yes
2020-03-12	10-K	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · NASDAQ
2020-03-12	10-K	Emerging growth company	Yes
2019-11-12	10-Q	Stock registered under Section 12(b)	Common Stock $0.001 par value per share · SLDB · NASDAQ
2019-11-12	10-Q	Smaller reporting company	No
2019-11-12	10-Q	Emerging growth company	Yes
2019-08-14	10-Q	Smaller reporting company	No
2019-08-14	10-Q	Emerging growth company	Yes
2019-05-13	10-Q	Smaller reporting company	No
2019-05-13	10-Q	Emerging growth company	Yes
2019-03-13	10-K	Smaller reporting company	No
2019-03-13	10-K	Emerging growth company	Yes
2019-03-13	10-K	Current in its reporting	No
2018-11-13	10-Q	Smaller reporting company	No
2018-11-13	10-Q	Emerging growth company	Yes

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Attovia Therapeutics, Inc. (ATTO)	United States	$0.828B
4D Molecular Therapeutics, Inc. (FDMT)	United States	$0.733B	-4.10
Candel Therapeutics, Inc. (CADL)	United States	$0.885B	-8.86
Sana Biotechnology, Inc. (SANA)	United States	$0.886B	-4.92
Odyssey Therapeutics, Inc. (ODTX)	United States	$0.960B
Aura Biosciences, Inc. (AURA)	United States	$0.639B	-5.61
Cullinan Therapeutics, Inc. (CGEM)	United States	$0.993B	-5.72
Monte Rosa Therapeutics, Inc. (GLUE)	United States	$1.002B	-12.81
Allogene Therapeutics, Inc. (ALLO)	United States	$0.574B	-4.33
Prime Medicine, Inc. (PRME)	United States	$0.557B	-3.54